Review Paper:
Nanotech approaches
in lung cancer research: A review
Koushik Anjali, Hariyani Poonam, Yadav Priya, Pareek Sonu and Dave Saurabh
Res. J. Chem. Environ.; Vol. 29(1); 85-94;
doi: https://doi.org/10.25303/291rjce085094; (2025)
Abstract
Advanced medical treatments are desperately needed as the world's leading cause
of death is cancer. New nanomaterials and nanocarriers have enabled a significant
push to improve the delivery of cancer medications. The multiple pharmacological,
biological and physical obstacles that the body presents which frequently obstruct
effective treatment, can be circumvented using nanoparticles (NPs). The basic objective
of the majority of nanocarrier uses is to prevent the medication from quickly degrading
after systemic administration and permit it to penetrate the cancer site at therapeutic
concentrations while reducing drug delivery to normal locations as much as possible
to reduce adverse effects. Lung cancer is a fatal condition that affects a lot of
individuals worldwide and it is becoming more common each year. The use of advanced
nanotechnology in the diagnosis and cure of lung tumor have grown in prominence.
Recent developments in nanotechnology have increased the field's application to
cancer prevention, therapy and diagnosis.
Researchers have access to a variety of alterable molecules for application in cancer
attributed to the specific physicochemical properties of substances at the nanostructures.
Various NP formulations were created as a result of this understanding and several
of these are presently undergoing clinical trials. This study gives a little background
on the scientific advancements in the nanotechnology sector, underscoring the significance
and necessity in the fight against lung cancer.
